» Articles » PMID: 31259093

Proteomic Identification of Membrane-associated Placental Protein 4 (MP4) As Perlecan and Characterization of Its Placental Expression in Normal and Pathologic Pregnancies

Abstract

Background: More than 50 human placental proteins were isolated and physico-chemically characterized in the 70-80s by Hans Bohn and co-workers. Many of these proteins turned to have important role in placental functions and diagnostic significance in pregnancy complications. Among these proteins was membrane-associated placental protein 4 (MP4), for which identity or function has not been identified yet. Our aim was to analyze the sequence and placental expression of this protein in normal and complicated pregnancies including miscarriage, preeclampsia and HELLP syndrome.

Methods: Lyophilized MP4 protein and frozen healthy placental tissue were analyzed using HPLC-MS/MS. Placental tissue samples were obtained from women with elective termination of pregnancy (first trimester controls, = 31), early pregnancy loss (EPL) ( = 13), early preeclampsia without HELLP syndrome ( = 7) and with HELLP syndrome ( = 8), late preeclampsia ( = 8), third trimester early controls ( = 5) and third trimester late controls ( = 9). Tissue microarrays were constructed from paraffin-embedded placentas ( = 81). Slides were immunostained with monoclonal perlecan antibody and evaluated using light microscopy and virtual microscopy. Perlecan was also analyzed for its expression in placentas from normal pregnancies using microarray data.

Results: Mass spectrometry-based proteomics of MP4 resulted in the identification of basement membrane-specific heparan sulfate proteoglycan core protein also known as perlecan. Immunohistochemistry showed cytoplasmic perlecan localization in syncytiotrophoblast and cytotrophoblasts of the villi. Perlecan immunoscore decreased with gestational age in the placenta. Perlecan immunoscores were higher in EPL compared to controls. Perlecan immunoscores were higher in early preeclampsia without and with HELLP syndrome and lower in late preeclampsia than in respective controls. Among patients with preeclampsia, placental perlecan expression positively correlated with maternal vascular malperfusion and negatively correlated with placental weight.

Conclusion: Our findings suggest that an increased placental perlecan expression may be associated with hypoxic ischaemic injury of the placenta in miscarriages and in early preeclampsia with or without HELLP syndrome.

Citing Articles

Cathepsin D elevates the fibrocalcific activity in human aortic valve cells through the ERK1/2-Sox9 pathway.

Yao Q, The E, Nedumaran B, Zhai Y, Ao L, Fullerton D Front Cardiovasc Med. 2024; 11:1410862.

PMID: 39380629 PMC: 11458440. DOI: 10.3389/fcvm.2024.1410862.


Proteoglycans: Systems-Level Insight into Their Expression in Healthy and Diseased Placentas.

Oravecz O, Balogh A, Romero R, Xu Y, Juhasz K, Gelencser Z Int J Mol Sci. 2022; 23(10).

PMID: 35628608 PMC: 9147780. DOI: 10.3390/ijms23105798.


Proteomic identification of Placental Protein 1 (PP1), PP8, and PP22 and characterization of their placental expression in healthy pregnancies and in preeclampsia.

Szabo S, Karaszi K, Romero R, Toth E, Szilagyi A, Gelencser Z Placenta. 2020; 99:197-207.

PMID: 32747003 PMC: 8314955. DOI: 10.1016/j.placenta.2020.05.013.


Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia.

Trout A, Rutkai I, Biose I, Bix G Int J Mol Sci. 2020; 21(2).

PMID: 31968632 PMC: 7013765. DOI: 10.3390/ijms21020679.


Dysregulation of Placental Functions and Immune Pathways in Complete Hydatidiform Moles.

King J, Wilson M, Hetey S, Kiraly P, Matsuo K, Castaneda A Int J Mol Sci. 2019; 20(20).

PMID: 31658584 PMC: 6829352. DOI: 10.3390/ijms20204999.

References
1.
Than N, Sumegi B, Than G, Berente Z, Bohn H . Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden Crystal protein. Placenta. 1999; 20(8):703-10. DOI: 10.1053/plac.1999.0436. View

2.
Jauniaux E, Watson A, Hempstock J, Bao Y, Skepper J, Burton G . Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000; 157(6):2111-22. PMC: 1885754. DOI: 10.1016/S0002-9440(10)64849-3. View

3.
Sanderson R . Heparan sulfate proteoglycans in invasion and metastasis. Semin Cell Dev Biol. 2001; 12(2):89-98. DOI: 10.1006/scdb.2000.0241. View

4.
Kvansakul M, HOPF M, Ries A, Timpl R, Hohenester E . Structural basis for the high-affinity interaction of nidogen-1 with immunoglobulin-like domain 3 of perlecan. EMBO J. 2001; 20(19):5342-6. PMC: 125277. DOI: 10.1093/emboj/20.19.5342. View

5.
Visegrady B, Than N, Kilar F, Sumegi B, Than G, Bohn H . Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng. 2001; 14(11):875-80. DOI: 10.1093/protein/14.11.875. View